NUPLAZID® (pimavanserin) logo - once daily - 34 mg capsules
NUPLAZID® (pimavanserin) logo - once daily - 34 mg capsules NUPLAZID® (pimavanserin) logo - once daily - 34 mg capsules

NUPLAZID is an FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis.

Find support in even more ways

Here you’ll find additional information and resources to help you learn more about hallucinations and delusions associated with Parkinson’s disease (PD) psychosis.

Downloadable resources

Icon for downloading a PDF file

PD-related Hallucinations and Delusions Fact Sheet

Download PDF
English Español 简体字 簡體字 Tiếng Việt 한글 русский Português 日本語
Icon for downloading a PDF file

NUPLAZID Fact Sheet

Download PDF
English Español 简体字 簡體字 Tiếng Việt 한글 русский Português 日本語
Icon for downloading a PDF file

Doctor Discussion Guide

Download PDF
Icon for downloading a PDF file

Guide to Navigating Telemedicine

Download PDF

Acadia Connect™


Enroll in Acadia Connect

Get Started
Icon for downloading a PDF file

Acadia Connect Patient and Caregiver Brochure

Download PDF
Innovation mark

Are Parkinson’s disease–related hallucinations and delusions affecting you or someone you love?

These symptoms may get worse over time. Don't wait, talk to your healthcare provider as soon as they occur. Ask if NUPLAZID is right for you or someone you love.

Brain activity icon reflects patients with PD-related hallucinations and delusions who may not have the ability to be able to identify whether or not what they'rre experiencing is real

Hallucinations and delusions may be more common than you think

Learn more
Icon of paper with check mark on it going into an envelope representing sign-up form for email communications

Get more information about PD-related hallucinations and delusions

Sign up now
Frequently 
Asked 
Questions

IMPORTANT SAFETY INFORMATION and INDICATION

WARNING: INCREASED RISK OF DEATH IN ELDERLY PATIENTS WITH DEMENTIA–RELATED PSYCHOSIS

  • Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).

  • NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

  • Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, swelling of the tongue, mouth, lips, or face, throat tightness, and shortness of breath.

  • NUPLAZID may cause serious side effects including:

    • QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.

    • Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about this possible side effect. Call your healthcare provider if you feel a change in your heartbeat.

  • Tell your healthcare provider about all the medicines you take. Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.
  • The common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
You can also call Acadia Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Dosage and Administration

The recommended dose of NUPLAZID is one 34 mg capsule once per day, taken by mouth.

NUPLAZID is available as 34 mg capsules and 10 mg tablets.

Please read the full Prescribing Information, including Boxed WARNING.

See Safety Information